Murínová, I.; Švidrnoch, M.; Gucký, T.; Hlaváč, J.; Michálek, P.; Slanař, O.; Šíma, M.
Population Pharmacokinetic Analysis Proves Superiority of Continuous Infusion in PK/PD Target Attainment with Oxacillin in Staphylococcal Infections. Antibiotics 2022, 11, 1736.
https://doi.org/10.3390/antibiotics11121736
AMA Style
Murínová I, Švidrnoch M, Gucký T, Hlaváč J, Michálek P, Slanař O, Šíma M.
Population Pharmacokinetic Analysis Proves Superiority of Continuous Infusion in PK/PD Target Attainment with Oxacillin in Staphylococcal Infections. Antibiotics. 2022; 11(12):1736.
https://doi.org/10.3390/antibiotics11121736
Chicago/Turabian Style
Murínová, Irena, Martin Švidrnoch, Tomáš Gucký, Jan Hlaváč, Pavel Michálek, Ondřej Slanař, and Martin Šíma.
2022. "Population Pharmacokinetic Analysis Proves Superiority of Continuous Infusion in PK/PD Target Attainment with Oxacillin in Staphylococcal Infections" Antibiotics 11, no. 12: 1736.
https://doi.org/10.3390/antibiotics11121736
APA Style
Murínová, I., Švidrnoch, M., Gucký, T., Hlaváč, J., Michálek, P., Slanař, O., & Šíma, M.
(2022). Population Pharmacokinetic Analysis Proves Superiority of Continuous Infusion in PK/PD Target Attainment with Oxacillin in Staphylococcal Infections. Antibiotics, 11(12), 1736.
https://doi.org/10.3390/antibiotics11121736